Fair pricing forum 2021: meeting report

Overview

The third biennial Fair Pricing Forum was held online on 13-15 and 20-22 April 2021 to continue the tradition of encouraging dialogue among various stakeholders, with the following objectives:

  1. To share countries’ experiences, including from the coronavirus disease (COVID-19) pandemic, in ensuring affordability and transparency of prices and costs of health products
  2. To advance discussion and knowledge on approaches and system factors pertaining to the pricing and R&D of pharmaceutical products for enhancing affordability, transparency, and innovation, and achieving health sustainable development goals
  3. To increase support for countries to achieve more affordable and fairer access to pharmaceutical products during the COVID-19 pandemic and beyond.

In total, more than 850 people from 125 Member States participated in the Forum and pre-Forum webinar.

WHO Team
Access to Medicines and Health Products (MHP), Health Product Policy and Standards (HPS), Medicines Selection, IP and Affordability (MIA)
Number of pages
58
Reference numbers
ISBN: 978-92-4-003858-5
Copyright